Stayble Therapeutics presented at Swedish Shareholders´ Association´s event Stora Aktiedagen Stockholm 2021
December 2021Stayble Therapeutics’ CEO Andreas Gerward gave a presentation on 30 November 2021 at Stora Aktiedagen Stockholm 2021, an event arranged by Swedish Shareholders´ Association´s. The event, which takes place between 29 November and 2 December 2021, is a physical event with a studio audience that is broadcasted live via Swedish Shareholders´ Association´s YouTube channel.
CEO Andreas Gerward presented the Company, the development of the injection treatment STA363 for chronic disc-related low back pain, and positive interim results from the ongoing clinical phase 2b study.
The presentation from November 30 is available at:
https://youtu.be/5isB5oucdJY
For more information
Andreas Gerward, CEO Stayble Therapeutics AB
andreas.gerward@stayble.se
+46 730 808 397